RxDoctor Payments Data

Steven Weber, MD

Family Medicine · Blanchester, OHNPI 1396701926

Payments from drug & device makers

$602in general payments, 2019–2025

Across 39 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$118
  • Pfizer$68
  • AstraZeneca$61
  • AbbVie$58
  • Johnson & Johnson$53
  • Lilly USA, LLC$51
  • plus $193 from 8 others

What the payments were for

  • Food & beverage$602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$602 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$46,377
Medicare patients
199
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter135$109,812
JardianceEmpagliflozin83$92,581
EliquisApixaban71$80,941
OzempicSemaglutide37$43,284
TrulicityDulaglutide25$30,748
MounjaroTirzepatide23$25,414
ProliaDenosumab12$20,258
Breo ElliptaFluticasone/Vilanterol27$18,287
FarxigaDapagliflozin Propanediol22$17,670
XareltoRivaroxaban14$14,532
Levemir FlexpenInsulin Detemir50$12,440
MyrbetriqMirabegron23$10,575
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm41$8,474
Novolog FlexpenInsulin Aspart21$7,762
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$38$128,099162 claims
Boehringer IngelheimJardiance$13$92,58183 claims
PfizerEliquis$68$80,94171 claims
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$51$59,21076 claims
Novo NordiskOzempic$118$43,28437 claims
AmgenProlia$36$20,25812 claims
AstraZenecaFarxiga$61$17,67022 claims
Johnson & JohnsonXarelto$53$14,53214 claims
Astellas Pharma US IncMyrbetriq$21$10,57523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Blanchester

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →